Ring Therapeutics Announces Publication Highlighting In Vivo Delivery and Tropism of the First Synthesized Human Anelloviruses Using a Recombinant Genome

3 years ago

Synthesized anellovirus particles demonstrated tissue-specific delivery in vivoCAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences…

Xtant Medical Appoints Scott Neils as Chief Financial Officer

3 years ago

BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…

Pennant Acquires Home Health Provider, Senior Living Real Estate Asset

3 years ago

EAGLE, Idaho, May 02, 2022 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant…

aTyr Pharma to Webcast Conference Call Reporting First Quarter 2022 Financial Results

3 years ago

Management to host conference call and webcast on May 9th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, May…

Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

3 years ago

Preclinical data suggest that SZN-413 can simultaneously address retinal non-perfusion and leakage in blood vessels in retinal vascular diseasesSOUTH SAN…

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9

3 years ago

DUBLIN, Ireland, May 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines…

LifeMD to Announce First Quarter Financial Results and Host Conference Call on Friday, May 13

3 years ago

NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that…

Join the MS Community and Raise Awareness for MS this May

3 years ago

MS Society invites Canadians to participate in nationwide MS Awareness Month activities TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- For…

Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease

3 years ago

DALLAS, May 02, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a company pioneering the development of a new class…

Mersana Therapeutics to Host First Quarter 2022 Conference Call on May 9, 2022

3 years ago

CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering…